Carey Olsen and Alter Domus have advised healthcare and sustainability investment firm Gyrus Capital on the final close of its €310m Gyrus Capital Fund II, exceeding the €215m raised for Gyrus Fund I in 2021.
Fund II consists of the Principal Fund and an open-ended co-investment vehicle, allowing Gyrus to make larger investments.
Fund II will be a continuation of Fund I, generating returns from investments into businesses operating in the healthcare and sustainability sectors.
Asset managers, public and private pension funds, insurance companies and family offices across Europe, North America, the Middle East and Asia have invested in Fund II.
The Fund has already completed its first investment, LRE Medical, a provider of diagnostic and life sciences devices based in Germany.
The Carey Olsen Guernsey corporate team advising Gyrus comprised Partner David Crosland, Senior Associate James Cooke and Associates Claire Cooke and Bhavik Mehta.
Alter Domus Guernsey has, alongside Carey Olsen, been providing fund administration solutions to Gyrus since its Fund I launch.
The fund services team supporting the Fund II closings included Director Tom Amy, Associate Director Katie Le Gallez, Manager James Arrol and Senior Officer Dan Guilbert.